Since Abcam's acquisition in 2023, founder Jonathan Milner has been making waves with his investment strategy. Discover his ...

Discover six exosome therapy companies developing these tiny extracellular vesicles to treat an array of diseases.

A biotech startup’s journey to unicorn status hinges on its leadership and the culture fostered within the organization. A ...

Advanced therapy medicinal products (ATMPs) are pushing the boundaries of medicine, offering hope for previously untreatable ...

Explore the role and challenges of AAV characterization, the significance of capsid filling, and the best methods to enhance ...

Delve into Sanofi's "play to win" strategy as investments are ramping up after their consumer health division's divestment.

The companies Treeline Biosciences, Kailera Therapeutics, and Seaport Therapeutics bagged the biggest private biotech ...

Therapeutic strides in biotech are advancing promising candidates in clinic to address different stages of sleep apnea and ...

What’s behind the dip in investment in the gene therapy sector? As promising as gene therapies are, one of the main issues for investors is that these types of treatments come with a lot of risk and, ...